Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 290 for “"BRCA"”.
-
Interpreting and making sense of uninformative results of testing for BRCA 1 and BRCA 2 cancer gene mutations
… found not to have a detectable mutation in their BRCA1 or BRCA2 cancer genes. Although the interpretation of genetic test results is relatively straightforward in families where a mutation has already been identified, little is known about how people who have had breast and/or ovarian cancer in …
-
Implications of BRCA-loss phenotype in epithelial ovarian carcinoma
Loss of BRCA1/BRCA2 function through genetic or epigenetic mechanisms is common in epithelial ovarian carcinomas (EOC), but because there are multiple potential mechanisms of loss, the overall frequency is unknown. We characterized loss of BRCA1/BRCA2 at the DNA, RNA and protein level from an …
-
Interrogation of Small Molecule Therapeutics for BRCA Deficient Cancers
… undescribed manner for the treatment of BRCA deficient cancers. ZINC 13403027, a clerodan-based natural product, was shown to target a protein called Rad52. Cancers possessing loss of function mutations in BRCA1 and BRCA2 are dependent on Rad52 for DNA repair and replication while normal, …
-
Ethical issues surrounding access to care for BRCA mutations
<p>Harmful BRCA (breast cancer susceptibility genes 1 and 2) mutations greatly increase women's risks of breast and/or ovarian cancer but are found in less than 1 per cent of the general population. Thus, care is targeted at women with strong family histories of breast and/or ovarian cancer. …
-
Predictors of Contralateral Breast Cancer In Brca Negative Women
… syndrome (HBOC) is caused by mutations in the BRCA1 and BRCA2 genes. Women carrying a mutation in these genes are at an increased risk to develop a second breast cancer. Contralateral breast cancer is the most common second primary cancer in patients treated for a first breast cancer. Other …
-
Miðlun erfðaupplýsinga um stökkbreytingu í BRCA geni : lögfræðileg álitaefni
… til þeirra sem bera stökkbreytingu í öðru hvoru BRCA geni, án þess að þeir óski sérstaklega eftir því. Hinn 16. október 2018 var lagt fram frumvarp til breytinga á lögum um vísindarannsóknir á heilbrigðissviði nr. 44/2014 á Alþingi á þann veg að hafa megi samband við einstaklinga sem bera …
-
Novel Approaches to Studying BRCA Variants of Unknown Clinical Significance
… and ovarian cancer susceptibility genes 1 and 2 (BRCA1 and BRCA2). Although BRCA genetic testing has aided in the identification of specific individuals at risk for breast and ovarian cancer, the large number of BRCA variants of unknown clinical significance (VUS) continues to complicate …
-
Από του στόματος αντισυλληπτική αγωγή σε γυναίκες φορείς μετάλλαξης BRCA
… φορείς παθογόνων μεταλλάξεων στα γονίδια BRCA1 και BRCA2 διατρέχουν σημαντικά αυξημένο διά βίου κίνδυνο εμφάνισης καρκίνου μαστού και καρκίνου ωοθηκών. Στο πλαίσιο αυτό, η από του στόματος αντισυλληπτική αγωγή αποτελεί παράγοντα ιδιαίτερου επιστημονικού και κλινικού ενδιαφέροντος, καθώς …
-
Η επίδραση της φορείας BRCA στην κύηση και τη γονιμότητα
Τα γονίδια BRCA1 και BRCA2 αποτελούν δύο γονίδια που παίζουν σπουδαίο ρόλο στην επιδιόρθωση μεταλλάξεων της διπλής αλυσίδας του DNA. Μεταλλάξεις σε αυτά τα γονίδια σχετίζονται με την εμφάνιση κακοηθειών με σημαντικότερες τον καρκίνο του μαστού και των ωοθηκών. Οι φορείς των μεταλλάξεων αυτών …
-
A Molecular Model For Transcriptional Regulation of BRCA-1 Expression
… in women. Mutations in the tumor suppressor gene BRCA-1 confer a high risk of breast tumor development. However, in sporadic breast cancers, which represent 90-95% of breast cancer cases, BRCA-1 expression is downregulated in the absence of mutations in the BRCA-1 gene. This suggests that …
-
Genetic testing for sale : implications of commercial BRCA testing in Canada
Ongoing research in the fields of genetics and biotechnology hold the promise of improved diagnosis and treatment of genetic diseases, and potentially the development of individually tailored pharmaceuticals and gene therapies. Difficulty, however, arises in determining how these services are to be …
-
Knowledge, Attitudes, and Utilization of Brca Testing Among Obstetricians and Gynecologists
… that is associated with mutations in the BRCA1 and BRCA2 genes. Carriers of BRCA mutations, both men and women, are at an increased risk for developing certain cancers. Carriers are most notably at an increased risk to develop breast and ovarian cancers; however an increased risk for …
-
Genes that matter: Survival modeling in TCGA-BRCA with treatment interactions.
… RNA-Seq data from female patients in the TCGA-BRCA cohort were analyzed. Univariate Cox proportional hazards models were used to screen genes, adjusting for age, race/ethnicity, treatment status, and cancer stage. A LASSO-penalized Cox regression was fit across 2000 random seeds to assess …
-
Integrative Analysis to Evaluate Similarity Between BRCAness Tumors and BRCA Tumors
The term "BRCAness" is used to describe breast-cancer patients who lack a germline mutation in BRCA1 or BRCA2, yet who are believed to express characteristics similar to patients who do have a germline mutation in BRCA1 or BRCA2. Although it is hypothesized that BRCAness is related to deficiency in …
-
DNA Methylierung ausgewählter BRCA- und Fanconi Anämie-Gene beim familiären Mammakarzinom
… stellen dabei hereditäre Mammakarzinome dar. Mit BRCA1- und dem Fanconi Anämie-Gen BRCA2 (FANCD1) sind zwei Gene bekannt, deren Keimbahnmutation einen Großteil der bekannten hereditären Mammakarzinome ausmacht. Trotzdem sind ca. die Hälfte der genetischen Ursachen des familiären Mammakarzinoms …
-
Untersuchung der Funktion von hSNM1B/Apollo im Fanconi-Anämie/BRCA- Reparaturweg
… bilden gemeinsam mit anderen Proteinen den FA/BRCA-DNA-Reparaturweg. Die Nuklease hSNM1B/Apollo ist neben ihrer Funktion beim Schutz der Telomere ebenfalls an der ICL-Reparatur beteiligt. Im Rahmen dieser Arbeit wurde ihre Rolle im FA /BRCA-Reparaturweg charakterisiert. Methodik: …
-
Professional and peer support in breast cancer care and BRCA surveillance
Radboud Universiteit Nijmegen, 12 november 2015
-
BRCA genes: conserved regions and the potential effect of missense changes
… of the breast cancer susceptibility genes, BRCA1 or BRCA2, confer a 50--80% lifetime risk of breast cancer. While 34% of BRCA mutations reported in the Breast Cancer Information Core are missense changes, only 8% are known to be dissease-associated. For BRCA1 30% of reported missense changes …
Page 1 of 15